일산병원

ILSAN HOSPITAL

Medical statistics

진료통계

암의 조직학적 형태별 분포현황

  • HOME
  • 진료통계
  • 주요통계 비젼
  • 암의 조직학적 형태별 분포현황

암의 조직학적 형태별 분포현황

(단위:건,%)
Behavior of
neoplasm		 코드 조직학적 진단명 2014년 2013년 전년대비
증감율
건수 구성비 건수 구성비
Carcinoma
in situ
(정상소재암)		 M80102 Carcinoma in situ, NOS 18 1.06 6 0.35 200.0
M80702 Squamous cell carcinoma in situ, NOS 12 0.70 13 0.77 -7.7
M80772 CIN III with severe dysplasia(C53._) 18 1.06 18 1.06 0.0
M80812 Bowen disease(C44._) 1 0.06 2 0.12 -50.0
M81202 Transitional cell carcinoma in situ - 0.00 2 0.12 -100.0
M81302 Papillary transitional cell carcinoma, non-invasive(C67._) 9 0.53 10 0.59 -10.0
M81402 Adenocarcinoma in situ, NOS 6 0.35 3 0.18 100.0
M81482 Glandular intraepithelial neoplasia, grade Ⅲ - 0.00 2 0.12 -100.0
M82012 Ductal carcinoma in situ, cribriform type(C50._) 1 0.06 - 0.00 -
M82102 Adenocarcinoma in situ in tubular adenoma 1 0.06 - 0.00 -
M82612 Adenocarcinoma in situ in villous adenoma 1 0.06 1 0.06 0.0
M82632 Adenocarcinoma in situ in tubulovillous adenoma 3 0.18 - 0.00 -
M85002 Ductal carcinoma in situ, NOS(C50._) 3 0.18 3 0.18 0.0
M85012 Ductal carcinoma in situ, comedo type(C50._) 2 0.12 4 0.24 -50.0
M85032 Intraductal papillary neoplasm with high grade intraepithelial neoplasia 1 0.06 1 0.06 0.0
Carcinoma in situ 합계 76 4.46 65 3.84 16.9
Malignant,
primary site
(악성, 원발부위암)		 M80003 Malignant neoplasm, NOS 297 17.42 262 15.47 13.4
M80043 Malignant tumor, spindle cell type - - 1 0.06 -100.0
M80103 Carcinoma, NOS 21 1.23 13 0.77 61.5
M80133 Large cell neuroendocrine carcinoma 1 0.06 - - -
M80203 Carcinoma, undifferentiated, NOS 1 0.06 2 0.12 -50.0
M80213 Carcinoma, anaplastic, NOS - - 1 0.06 -100.0
M80323 Spindle cell carcinoma, NOS 1 0.06 - - -
M80333 Sarcomatoid carcinoma 3 0.18 1 0.06 200.0
M80413 Small cell carcinoma, NOS 27 1.58 20 1.18 35.0
M80433 Small cell carcinoma, fusiform cell - - 1 0.06 -100.0
M80463 Non-small cell carcinoma(C34._) 44 2.58 33 1.95 33.3
M80503 Papillary carcinoma, NOS 3 0.18 - - -
M80513 Verrucous squamous cell carcinoma - - 1 0.06 -100.0
M80523 Papillary squamous cell carcinoma 2 0.12 - - -
M80703 Squamous cell carcinoma, NOS 97 5.69 109 6.43 -11.0
M80713 Squamous cell carcinoma, large cell, keratinizing 1 0.06 1 0.06 0.0
M80723 Squamous cell carcinnoma, large cell, nonkeratinizing, NOS 5 0.29 4 0.24 25.0
M80763 Squamous cell carcinoma, microinvasive - - 1 0.06 -100.0
M80903 Basal cell carcinoma, NOS(C44._) 7 0.41 6 0.35 16.7
M80943 Mixed basal-squamous cell carcinoma(C44._) - - 1 0.06 -100.0
M81203 Transitional cell carcinoma, NOS 31 1.82 18 1.06 72.2
M81303 Papillary transitional cell carcinoma (C67._) 35 2.05 26 1.53 34.6
M81403 Adenocarcinoma, NOS 364 21.35 379 22.37 -4.0
M81603 Cholangiocarcinoma(C22.1, C24.0) 38 2.23 19 1.12 100.0
M81623 Klatskin tumor(C22.1, C24.0) 7 0.41 11 0.65 -36.4
M81703 Hepatocellular carcinoma, NOS(C22.0) 86 5.04 87 5.14 -1.1
M82003 Adenoid cystic carcinoma 3 0.18 1 0.06 200.0
M82103 Adenocarcinoma in tubular adenoma 4 0.23 4 0.24 0.0
M82113 Tubular adenocarcinoma 68 3.99 48 2.83 41.7
M82303 Solid carcinoma, NOS 2 0.12 - - -
M82403 Neuroendocrine tumor, grade 1 5 0.29 2 0.12 150.0
M82463 Neuroendocrine carcinoma, NOS 2 0.12 2 0.12 0.0
M82473 Merkel cell carcinoma(C44._) 1 0.06 - - -
M82493 Neuroendocrine tumor, grade 2 1 0.06 - - -
M82503 Bronchiolo-alveolar adenocarcinoma, NOS(C34._) 3 0.18 12 0.71 -75.0
M82523 Bronchiolo-alveolar carcinoma, non-mucinous(C34._) - - 1 0.06 -100.0
M82553 Adenocarcinoma with mixed subtypes - - 1 0.06 -100.0
M82603 Papillary adenocarcinoma, NOS 147 8.62 190 11.22 -22.6
M82613 Adenocarcinoma in villous adenoma - - 1 0.06 -100.0
M82623 Villous adenocarcinoma - - 1 0.06 -100.0
M82633 Adenocarcinoma in tubulovillous adenoma 2 0.12 16 0.94 -87.5
M82903 Hurthle cell carcinoma(C73.9) 1 0.06 - - -
M83103 Clear cell adenocarcinoma, NOS 5 0.29 12 0.71 -58.3
M83123 Renal cell carcinoma, NOS(C64.9) 21 1.23 16 0.94 31.3
M83303 Follicular carcinoma, NOS(C73.9) - - 1 0.06 -100.0
M83353 Follicular carcinoma, minimally, invasive(C73.9) 2 0.12 1 0.06 100.0
M83403 Papillary carcinoma, follicular variant(C73.9) 1 0.06 - - -
M83703 Adrenal cortical carcinoma(C74.0) 1 0.06 - - -
M83803 Endometrioid carcinoma, NOS 13 0.76 6 0.35 116.7
M83843 Adenocarcinoma, endocervical type 1 0.06 - - -
M83903 Adnexal carcinoma(C44._) - - 1 0.06 -100.0
M84013 Apocrine adenocarcinoma - - 1 0.06 -100.0
M84103 Sebaceous carcinoma(C44._) - - 1 0.06 -100.0
M84303 Mucoepidermoid carcinoma - - 2 0.12 -100.0
M84413 Serous adenocarcinoma, NOS 4 0.23 6 0.35 -33.3
M84613 Serous surface papillary carcinoma(C56.9) 1 0.06 - - -
M84803 Mucinous adenocarcinoma 11 0.65 13 0.77 -15.4
M84813 Mucin-producing adenocarcinoma - - 1 0.06 -100.0
M84903 Signet ring cell carcinoma 26 1.52 29 1.71 -10.3
M85003 Infiltrating duct carcinoma, NOS(C50._) 64 3.75 64 3.78 0.0
M85203 Lobular carcinoma, NOS(C50._) - - 2 0.12 -100.0
M85503 Acinar cell carcinoma 25 1.47 38 2.24 -34.2
M85513 Acinar cell cystadenocarcinoma - - 1 0.06 -100.0
M85603 Adenosquamous carcinoma 3 0.18 8 0.47 -62.5
M85703 Adenocarcinoma with squamous metaplasia - - 1 0.06 -100.0
M85743 Carcinoma with neuroendocrine differentiation - - 1 0.06 -100.0
M85753 Metaplastic carcinoma, NOS 1 0.06 - - -
M85813 Thymoma, type A, malignant(C37.9) 1 0.06 - - -
M85863 Thymic carcinoma, NOS(C37.9) - - 1 0.06 -100.0
M87203 Malignant melanoma, NOS (except jubenile melanoma M-8770/0) 6 0.35 3 0.18 100.0
M87213 Nodular melanoma(C44._) 1 0.06 - - -
M88003 Sarcoma, NOS 1 0.06 - - -
M88023 Pleomorphic cell sarcoma 3 0.18 - - -
M88053 Undifferentiated sarcoma 1 0.06 - - -
M88063 Desmoplastic small round cell tumor - - 1 0.06 -100.0
M88113 Fibromyxosarcoma 1 0.06 1 0.06 0.0
M88303 Malignant fibrous histiocytoma 2 0.12 - - -
M88323 Dermatofibrosarcoma, NOS(C44._) 1 0.06 - - -
M88503 Liposarcoma, NOS - - 1 0.06 -100.0
M88523 Myxoid liposarcoma 1 0.06 1 0.06 0.0
M88903 Leiomyosarcoma, NOS 2 0.12 3 0.18 -33.3
M88953 Myosarcoma - - 1 0.06 -100.0
M89003 Rhabdomyosarcoma, NOS 1 0.06 - - -
M89313 Endometrial stromal sarcoma, low grade(C54.1) 1 0.06 - - -
M89363 Gastrointestinal stromal tumor, malignant 7 0.41 11 0.65 -36.4
M89503 Mullerian mixed tumor(C54._) - - 1 0.06 -100.0
M89703 Hepatoblastoma(C22.0) - - 1 0.06 -100.0
M89803 Carcinosarcoma, NOS 1 0.06 2 0.12 -50.0
M89823 Myoepithelial carcinoma 1 0.06 - - -
M90203 Phyllodes tumor, malignant(C50._) 1 0.06 - - -
M90503 Mesothelioma, malignant 2 0.12 1 0.06 100.0
M90603 Dysgerminoma - - 1 0.06 -100.0
M90613 Seminoma, NOS(C62._) 1 0.06 1 0.06 0.0
M90803 Teratoma, malignant, NOS 3 0.18 - - -
M91203 Angiosarcoma 2 0.12 3 0.18 -33.3
M92503 Osteoclastoma, malignant(C40._, C41._) - - 1 0.06 -100.0
M93823 Anaplastic oligoastrocytoma(C71._) 3 0.18 1 0.06 200.0
M94003 Astrocytoma, NOS(C71._) 1 0.06 - - -
M94013 Astrocytoma, anaplastic(C71._) 1 0.06 - - -
M94103 Protoplasmic astrocytoma(C71._) 1 0.06 - - -
M94243 Pleomorphic xanthoastrocytoma(C71._) - - 1 0.06 -100.0
M94403 Glioblastoma, NOS(C71._) 6 0.35 5 0.30 20.0
M94503 Oligodendroglioma, NOS(C71._) - - 1 0.06 -100.0
M94513 Oligodendroglioma, anaplastic(C71._) 1 0.06 - - -
M94733 Primitive neuroectodermal tumor, NOS(C71._) - - 1 0.06 -100.0
M95223 Olfactory neuroblastoma(C30.0) - - 1 0.06 -100.0
M95303 Meningioma, malignant - - 1 0.06 -100.0
M95903 Malignant lymphoma, NOS 1 0.06 - - -
M96503 Hodgkin lymphoma, NOS - - 2 0.12 -100.0
M96513 Classical Hodgkin lymphoma, lymphocyte-rich - - 1 0.06 -100.0
M96533 Hodgkin lymphoma, lymphocyte depletion, NOS 1 0.06 - - -
M96733 Mantle cell lymphoma(includes all variant: blastic, pleomorphic, small cell) - - 2 0.12 -100.0
M96803 Malignant lymphoma, large B-cell, diffuse, NOS 19 1.11 19 1.12 0.0
M96873 Burkitt lymphoma, NOS 1 0.06 1 0.06 0.0
M96903 Follicular lymphoma, NOS 1 0.06 1 0.06 0.0
M96953 Follicular lymphoma, grade 1 - - 1 0.06 -100.0
M96983 Folloicular lymphoma, grade 3 1 0.06 - - -
M96993 Marginal zone B-cell lymphoma, NOS 4 0.23 3 0.18 33.3
M97023 Mature T-cell lymphoma, NOS 4 0.23 - - -
M97053 Peripheral T-cell lymphoma, AILD(Angioimmunoblastic Lymphadenopathy with
Dysproteinemia)[obs]		 - - 1 0.06 -100.0
M97083 Subcutaneous panniculitis-like T-cell lymphoma - - 1 0.06 -100.0
M97143 Anaplastic large cell lymphoma, T cell and Null cell type 1 0.06 - - -
M97193 NK/T-cell lymphoma, nasal and nasal-type 3 0.18 1 0.06 200.0
M97313 Plasmacytoma, NOS - - 1 0.06 -100.0
M97323 Multiple myeloma(C42.1) 4 0.23 12 0.71 -66.7
M97513 Eosinophilic granuloma 1 0.06 1 0.06 0.0
M98013 Acute leukemia, NOS 1 0.06 2 0.12 -50.0
M98233 Chronic lymphocytic leukemia - - 2 0.12 -100.0
M98353 Acute lymphatic leukemia - - 1 0.06 -100.0
M98613 Acute myeloid leukemia, NOS - - 2 0.12 -100.0
M98633 Chronic myeloid leukemia, NOS 1 0.06 1 0.06 0.0
M98663 Acute promyelocytic leukemia, NOS - - 1 0.06 -100.0
M98673 Acute myelomonocytic leukemia - - 1 0.06 -100.0
M98723 Acute myeloblastic leukemia 5 0.29 2 0.12 150.0
M98743 Acute myeloid leukemia with maturation 1 0.06 - - -
M99453 Chronic myelomonocytic leukemia, NOS - - 1 0.06 -100.0
M99503 Polycythemia vera - - 3 0.18 -100.0
M99623 Essential thrombocythemia 1 0.06 1 0.06 0.0
M99803 Refractory anemia 1 0.06 - - -
M99833 RAEB Ⅰ 1 0.06 1 0.06 0.0
M99853 Refractory cytopenia with multilineage dysplasia - - 1 0.06 -100.0
M99893 Myelodysplastic syndrome, NOS 5 0.29 7 0.41 -28.6
Malignant, primary site 합계 1,599 93.78 1,599 94.39 0.0
총합계 1,705 100.00 1,694 100.00 0.6
 

  • (우)10444 경기도 고양시 일산동구 일산로 100(백석1동 1232번지) 대표전화 : 031-900-0114 팩스 : 031-900-0049
  • Copyright ＠ NATIONAL HEAL TH INSURANCE SERVICE IL SANHOSPITAL. ALL RIGHTS RESERVED.